Folic acid fortification of the food supply: Potential benefits and risks for the elderly population

JAMA

Volumn 276, Issue 23, 1996, Pages 1879-1885

  Tucker, Katherine L ^a   Mahnken, Brenda ^a   Wilson, Peter W F ^b   Jacques, Paul ^a   Selhub, Jacob ^a  

^a TUFTS UNIVERSITY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; ARTICLE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; FOOD COMPOSITION; GERIATRICS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VITAMIN INTAKE;

EID: 0029955917     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.23.1879     Document Type: Article

References (49)

1. Food and Drug Administration, Dept of Health and Human Services. Food Standards: Amendment of the Standards of Identity for Enriched Grain Products to Require Addition of Folic Acid, 21 CFR §§ 136, 137, and 139 (1993). Docket No. 91N-100S.
2. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep. 1992; 41(No. RR-14):1-7.
3. Food labeling: health claims and label statements: folate and neural tube defects. Federal Register. October 14, 1993;58:53254-53295.
4. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register. March 5, 1996;61: 8781-8797.
5. Centers for Disease Control and Prevention Working Group on Folic Acid. Position Paper on Folic Acid Food Fortification and the Prevention of Spina Bifida and Anencephaly (SBA). Atlanta, Ga: Centers for Disease Control and Prevention; 1993.
6. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.
7. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286-291.
8. Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr, ed. Atherosclerotic Cardiovascular Disease. Hemostasis, and Endothelial Function. New York, NY: Marcel Dekker Inc; 1992:183-236.
9. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocsrdial infarction in US physicians. JAMA. 1992;268:877-881.
10. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 1995;274:1049-1057.
11. Brattstrom LE, Israeisson B, Jeppsson J-O, Hultberg BL. Folic acid: an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest, 1988;48:215-221.
12. Brattstrom L, Israelsson B, Norrving B, et al. Impaired homocysteine metabolism in early onset cerebral and peripheral occlusive arterial disease: effects of pyridoxine and folic acid treatment. Atherosclerosis. 1990;81:51-60.
13. Lindgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattstrom L. Plasma homocysteine in acute myocardial infarction: homocysteine lowering effect of folic acid. J Intern Med. 1995;237:381-388.
14. Glueck CJ, Shaw P, Lang JE, Tracy T, Sieve-Smith L, Wang Y. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol. 1995;75:132-136.
15. 6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr. 1993;57:47-53.
16. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr. 1994;124:1927-1933.
17. 6 and folic acid on mild hyperhomocysteinemia in vascular patients. J Inherit Metab Dis. 1994;17:159-162.
18. 6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg. 1994;20:933-940.
19. Crane NT, Wilson DB, Cook A, Lewis CJ, Yetley EA, Rader JI. Evaluating food fortification options: general principles revisited with folic acid. Am J Public Health. 1995;85:660-666.
20. Ross FJ, Belding H, Paegel BL. The development and progression of subacute combined degeneration of the spinal cord in patients with pernicious anaemia treated with synthetic pteroylglutamic (folic) acid. Blood. 1948;3:68-90.
21. Ellison ABC. Pernicious anemia masked by multivitamins containing folic acid. JAMA. 1960;173: 240-243.
22. Baldwin JN, Dalessio DJ. Folic acid therapy and spinal-cord degeneration in pernicious anemia. N Engl J Med. 1961;264:1339-1342.
23. Scott JM, Weir DG. The methyl folate trap: a physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anemia. Lancet. 1981;2:337-340.
24. Lindenbaum J, Rosenberg IH, Wilson PWF, Stabler SP, Allen R. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr. 1994;60:2-11.
25. 6 occur commonly in elderly people. Am J Clin Nutr. 1993;58:468-476.
26. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency, I: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol. 1990;34:90-98.
27. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318:1720-1728.
28. Carmel R. Pernicious anemia: the expected findings of very low serum cobalamin levels, anemia, and macrocytosis are often lacking. Arch Intern Med. 1988;148:1712-1714.
29. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood. 1990;76:871-881.
30. 12) levels. Arch Intern Med. 1988;148: 1705-1707.
31. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine. 1991;70:229-245.
32. Dawber TR, Moore FE, Mann GV. Coronary heart disease in the Framingham Study. Am J Public Health. 1957;47(suppl 4):4-24.
33. Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, Brown ML. Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc. 1987; 87:43-47.
34. Jacques PF, Sulsky SI, Sadowski JA, Phillips JCC, Rush D, Willett WC. Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status. Am J Clin Nutr. 1993;57:182-189.
35. Tamura T, Freeberg LE, Cornwell PE. Inhibition by EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron. Clin Chem. 1990;36:1993.
36. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43-52.
37. Minnesota Nutrient Data System (NDS). Food database version 9. Nutrient database version 24. Minneapolis: Nutrition Coordination Center, University of Minnesota; 1995.
38. Jacobs DS, ed. Laboratory Test Handbook. 2nd ed. Hudson (Cleveland), Ohio: Lexi-Comp Inc: 1990.
39. SAS/STAT Version 6.08. Cary, NC: SAS Institute Inc; 1989.
40. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
41. Pedersen AB, Mosbech J. Morbidity of pernicious anemia: incidence, prevalence and treatment in a Danish county. Acta Med Scand. 1969;185:449-452.
42. Borch K, Lindberg G. Prevalence and incidence of pernicious anemia: an evaluation for gastric screening. Scand J Gastroenierol. 1984;19:154-160.
43. Romano PS, Waitzman NJ, Scheffler RM, Pi RD. Folic acid fortification of grain: an economic analysis. Am J Public Health. 1995;85:667-676.
44. 12 deficiency? Q J Med. 1995;88:357-364.
45. 12 deficiency is the primary cause of megaloblastic anaemia in Zimbabwe. Br J Haematol. 1994;86:844-850.
46. Russell RM. Changes in gastrointestinal function attributed to aging. Am J Clin Nutr. 1992;55 (suppl 6):1203S-1207S.
47. Chosy JJ, Clatanoff DV, Schilling RF. Responses to small doses of folic acid in pernicious anemia. Am J Clin Nutr. 1962;10:349-350.
48. Savage DG, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Baillieres Clin Haematol. 1995;8:657-678.
49. Lederle FA. Oral cobalamin for pernicious anemia: medicine's best kept secret? JAMA. 1991;265: 94-95.